Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Delta-Fly raises ¥3.3B in IPO

Chris Lieu
October 5, 2018 7:53 PM UTC

Cancer company Delta-Fly Pharma Inc. (Tokyo:4598) raised ¥3.3 billion ($29.3 million) in IPO on Oct. 3 through the sale of 700,000 shares at ¥4,770.

The price values the company at ¥20.5 billion ($180.1 million). Delta-Fly had set a range of ¥4,570-¥4,770; at the ¥4,670 midpoint, it would have raised ¥3.3 billion ($28.7 million) for a valuation of ¥20.1 billion ($176.3 million)...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Delta-fly Pharma Inc.